These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 11592347
1. Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide. Sloan JA, Atherton P, Reid J, Pitot HC, Erlichman C, Schaaf L. Cancer Chemother Pharmacol; 2001 Sep; 48(3):241-9. PubMed ID: 11592347 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick J. Cancer Chemother Pharmacol; 2008 Nov; 62(6):1027-37. PubMed ID: 18278496 [Abstract] [Full Text] [Related]
10. Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan. Ando Y, Ueoka H, Sugiyama T, Ichiki M, Shimokata K, Hasegawa Y. Ther Drug Monit; 2002 Feb; 24(1):111-6. PubMed ID: 11805731 [Abstract] [Full Text] [Related]
12. Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide. Klein CE, Gupta E, Reid JM, Atherton PJ, Sloan JA, Pitot HC, Ratain MJ, Kastrissios H. Clin Pharmacol Ther; 2002 Dec; 72(6):638-47. PubMed ID: 12496745 [Abstract] [Full Text] [Related]
13. Clinical pharmacokinetics of irinotecan and its metabolites: a population analysis. Xie R, Mathijssen RH, Sparreboom A, Verweij J, Karlsson MO. J Clin Oncol; 2002 Aug 01; 20(15):3293-301. PubMed ID: 12149304 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. Machida Y, Onishi H, Kurita A, Hata H, Morikawa A, Machida Y. J Control Release; 2000 May 15; 66(2-3):159-75. PubMed ID: 10742577 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer. Pharmacology and Molecular Mechanisms Group of the European Organization for Research and Treatment of Cancer. Canal P, Gay C, Dezeuze A, Douillard JY, Bugat R, Brunet R, Adenis A, Herait P, Lokiec F, Mathieu-Boue A. J Clin Oncol; 1996 Oct 15; 14(10):2688-95. PubMed ID: 8874328 [Abstract] [Full Text] [Related]
19. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J, North American Brain Tumor Consortium study. Neuro Oncol; 2004 Jan 15; 6(1):44-54. PubMed ID: 14769140 [Abstract] [Full Text] [Related]
20. Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer. Fujitani K, Tsujinaka T, Hirao M. Oncology; 2003 Jan 15; 64(2):111-5. PubMed ID: 12566907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]